ReviewSichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition2022
[Application Progress of Dual RNA Sequencing in Microbial Research].
Review in Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Transcriptomic analysis of the response ofFrontiers in microbiology · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The human body is colonized by densely-populated and structurally complex communities of microorganisms. The microbiota interact not only with their host cells, but also with other microbiota. Dual RNA sequencing (Dual RNA-seq) can be used to conduct simultaneous analysis of the dynamic changes of gene expression of two (or more) interactive species, and to obtain thus, through the interaction model diagram, the inter-species regulatory relationship of genes of different species, and hence the interaction mechanism between species. We herein reviewed the application status and development prospects of Dual RNA-seq in the research of intestinal, respiratory, skin and oral microbes. Since the concept of Dual RNA-seq was first introduced, the technology has been applied to a range of infection models. Direct investigation into the dynamic interactions between species at the molecular level will contribute to the better understanding of the physiological changes of pathogens and hosts during the course of infection, and thus help reveal potential new targets or biomarkers. However, the Dual RNA-seq technology is still in its early stage of development, and there are some limitations in the experimental technology. For example, due to the dynamic nature of the interaction between species, there are urgent problems awaiting solutions, such as the optimal experimental conditions, the selection of sampling sites and how to achieve real-time observation. In addition, due to the large amount of bioinformatics data of Dual RNA-seq, further research is needed to explore for ways to process the interaction information quickly and flexibly.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.